| Primary |
| Osteoporosis |
47.7% |
| Rheumatoid Arthritis |
12.7% |
| Hypertension |
9.7% |
| Gastritis |
4.2% |
| Constipation |
3.0% |
| Insomnia |
3.0% |
| Diabetes Mellitus |
2.5% |
| Lumbar Spinal Stenosis |
2.1% |
| Systemic Lupus Erythematosus |
2.1% |
| Angina Pectoris |
1.7% |
| Hyperlipidaemia |
1.7% |
| Parkinson's Disease |
1.7% |
| Autoimmune Hepatitis |
1.3% |
| Intervertebral Disc Protrusion |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Abdominal Pain Upper |
0.8% |
| Anxiety |
0.8% |
| Cardiac Failure |
0.8% |
| Gastric Ulcer |
0.8% |
| Gastritis Prophylaxis |
0.8% |
|
| Femur Fracture |
44.6% |
| Osteomyelitis |
13.5% |
| Osteonecrosis Of Jaw |
8.1% |
| Atypical Femur Fracture |
6.8% |
| Ulna Fracture |
4.1% |
| Retinal Detachment |
2.7% |
| Sepsis |
2.7% |
| Atypical Fracture |
1.4% |
| Blood Pressure Abnormal |
1.4% |
| Drug Eruption |
1.4% |
| Epiglottitis |
1.4% |
| Febrile Neutropenia |
1.4% |
| Gastric Cancer |
1.4% |
| Haemorrhagic Anaemia |
1.4% |
| Intramedullary Rod Insertion |
1.4% |
| Liver Disorder |
1.4% |
| Myelodysplastic Syndrome |
1.4% |
| Neutrophil Count Decreased |
1.4% |
| Oesophageal Stenosis |
1.4% |
| Overdose |
1.4% |
|
| Secondary |
| Rheumatoid Arthritis |
15.8% |
| Osteoporosis |
14.4% |
| Prophylaxis |
12.2% |
| Drug Use For Unknown Indication |
10.9% |
| Product Used For Unknown Indication |
7.9% |
| Hypertension |
6.2% |
| Influenza |
4.1% |
| Osteoarthritis |
3.8% |
| Systemic Lupus Erythematosus |
3.4% |
| Diabetes Mellitus |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Idiopathic Pulmonary Fibrosis |
2.3% |
| Gastritis |
2.1% |
| Metastases To Bone |
2.1% |
| Back Pain |
1.7% |
| Aplastic Anaemia |
1.5% |
| Helicobacter Infection |
1.5% |
| Pain |
1.5% |
| Pemphigoid |
1.5% |
| Gastric Ulcer |
1.3% |
|
| Femur Fracture |
12.9% |
| Osteomyelitis |
10.0% |
| Pneumonia |
10.0% |
| Weight Decreased |
8.6% |
| White Blood Cell Count Decreased |
7.1% |
| Tooth Extraction |
5.7% |
| Interstitial Lung Disease |
4.3% |
| Leukopenia |
4.3% |
| Rash |
4.3% |
| Skin Ulcer |
4.3% |
| Osteonecrosis |
2.9% |
| Osteonecrosis Of Jaw |
2.9% |
| Platelet Count Decreased |
2.9% |
| Pneumocystis Jiroveci Pneumonia |
2.9% |
| Pneumonia Fungal |
2.9% |
| Pulmonary Tuberculosis |
2.9% |
| Respiratory Failure |
2.9% |
| Respiratory Rate Decreased |
2.9% |
| Treatment Noncompliance |
2.9% |
| Urine Abnormality |
2.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
39.5% |
| Prophylaxis |
11.7% |
| Osteoporosis |
10.6% |
| Product Used For Unknown Indication |
6.3% |
| Hypertension |
6.1% |
| Gastritis |
3.1% |
| Drug Use For Unknown Indication |
2.5% |
| Constipation |
2.3% |
| Insomnia |
2.0% |
| Multiple Myeloma |
1.9% |
| Osteoporosis Prophylaxis |
1.7% |
| Antibiotic Prophylaxis |
1.6% |
| Diabetes Mellitus |
1.5% |
| Infection Prophylaxis |
1.5% |
| Asthma |
1.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Hyperlipidaemia |
1.3% |
| Castleman's Disease |
1.2% |
| Idiopathic Thrombocytopenic Purpura |
1.2% |
| Gastric Ulcer |
1.1% |
|
| Interstitial Lung Disease |
12.3% |
| Pneumocystis Jiroveci Pneumonia |
11.4% |
| White Blood Cell Count Decreased |
9.9% |
| Pyrexia |
6.9% |
| Vomiting |
5.4% |
| Renal Impairment |
5.1% |
| Liver Disorder |
4.8% |
| Pneumonia |
4.5% |
| Upper Respiratory Tract Inflammation |
4.2% |
| Sepsis |
3.9% |
| Pulmonary Tuberculosis |
3.6% |
| Rash |
3.6% |
| Urinary Tract Infection |
3.3% |
| Herpes Zoster |
3.0% |
| Nausea |
3.0% |
| Platelet Count Decreased |
3.0% |
| Respiratory Failure |
3.0% |
| Thrombocytopenia |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Cerebral Infarction |
2.7% |
|
